Complement Activation in Cystic Fibrosis Respiratory Fluids: in Vivo and in Vitro Generation of C5a and Chemotactic Activity

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Pediatric Research

• Publication date

  1986-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1203/00006450-198612000-00014PMID 3540828
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IgG proteolytic activity of Pseudomonas aeruginosa in cystic fibrosis.

  1985cited by this paper
• Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis.

  1984cited by this paper
• Demonstration of a free elastolytic metalloenzyme in human lung lavage fluid and its relationship to alpha 1-antiprotease.

  1984cited by this paper
• Granulocyte neutral proteases and Pseudomonas elastase as possible causes of airway damage in patients with cystic fibrosis.

  1984cited by this paper
• Activation of the alternative pathway of human complement by the extracellular slime glycolipoprotein of Pseudomonas aeruginosa.

  1982cited by this paper
• Cystic fibrosis pseudomonas opsonins. Inhibitory nature in an in vitro phagocytic assay.

  1981cited by this paper
• Human monocyte spreading induced by factor Bb of the alternative pathway of complement activation. A possible role for C5 in monocyte spreading

  1981cited by this paper
• Pseudomonas in cystic fibrosis sylph or sycophant?

  1981cited by this paper
• [Extracellular toxins of Pseudomonas aeruginosa. II. Effect of two proteases on human immunoglobulins IgG, IgA and secretory IgA (author's transl)].

  1981cited by this paper
• Elastase and lysozyme activities in human alveolar macrophages. Effects of cigarette smoking.

  1980cited by this paper
• Human alveolar macrophage-derived chemotactic factor for neutrophils. Stimuli and partial characterization.

  1980cited by this paper
• Immune complexes and humoral response to Pseudomonas aeruginosa in cystic fibrosis.

  1980cited by this paper
• Alveolar macrophage-derived chemotactic factor: kinetics of in vitro production and partial characterization.

  1980cited by this paper
• Bronchoalveolar lavage.

  1980cited by this paper
• Digestion of the fifth component of complement by leukocyte enzymes. Sequential generation of chemotactic activities for leukocytes and for tumor cells.

  1979influential reference
• Complement fragments, alveolar macrophages, and alveolitis.

  1979cited by this paper
• Receptor-mediated binding and internalization of leukocyte elastase by alveolar macrophages in vitro.

  1979cited by this paper
• Complement in cystic fibrosis

  1978cited by this paper
• Recommended standardized procedures of pulmonary function testing

  1978cited by this paper
• Animal models of emphysema.

  1978cited by this paper
• Immunologic reactivity of the lung: the in vivo and in vitro generation of a neutrophil chemotactic factor by alveolar macrophages.

  1978cited by this paper
• Radiolabeling of proteins by reductive alkylation with [14C]formaldehyde and sodium cyanoborohydride.

  1978cited by this paper
• Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey.

  1977cited by this paper
• Chronic bronchitis and cystic fibrosis: two chronic obstructive lung diseases of adults.

  1977cited by this paper
• Third component of human complement: purification from plasma and physicochemical characterization.

  1976cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• Elastase of Pseudomonas aeruginosa: Inactivation of Complement Components and Complement-Derived Chemotactic and Phagocytic Factors

  1974cited by this paper
• A new prognostic score and clinical evaluation system for cystic fibrosis.

  1973cited by this paper
• A manual of quantitative immunoelectrophoresis. Methods and applications.

  1973cited by this paper
• Granulocyte chemotaxis: an improved in vitro assay employing 51 Cr-labeled granulocytes.

  1973cited by this paper
• Pseudomonas aeruginosa: Immune Status in Patients with Cystic Fibrosis

  1972cited by this paper
• Macrophage proteinase and inflammation: the production of chemotactic activity from the fifth complement by macrophage proteinase.

  1972cited by this paper
• Pulmonary Function Testing in Children: Techniques and Standards

  1972cited by this paper
• Cleavage of structural proteins during

  1970cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• C5 chemotactic fragments produced by an enzyme in lysosomal granules of neutrophils.

  1970cited by this paper
• Quantitative bacteriological analysis of sputum as a test of antibiotic efficacy.

  1967cited by this paper
• PSEUDOMONAS AERUGINOSA ELASTASE. ISOLATION, CRYSTALLIZATION, AND PRELIMINARY CHARACTERIZATION.

  1965cited by this paper
• Immunochemical quantitation of antigens by single radial immunodiffusion.

  1965cited by this paper
• Metabolism of Plasma Proteins

  1964cited by this paper
• Pulmonary function in the newborn infant. I. Methods: ventilation and gaseous metabolism.

  1962cited by this paper
• The reaction between elastase and elastic tissue. 4. Soluble elastins.

  1961cited by this paper
• Plethysmographic determination of the volume of gas trapped in the lungs.

  1956cited by this paper

• Subversion of the Complement System by Pseudomonas aeruginosa

  2023cites this paper
• Tissue-localized immune responses in people with cystic fibrosis and respiratory nontuberculous mycobacteria infection.

  2022cites this paper
• Pseudomonas aeruginosa adaptation in cystic fibrosis patients increases C5a levels and promotes neutrophil recruitment

  2022cites this paper
• Development and characterization of novel anti‐C5 monoclonal antibodies capable of inhibiting complement in multiple species

  2019cites this paper
• Profiling the susceptibility of Pseudomonas aeruginosa strains from acute and chronic infections to cell-wall-targeting immune proteins

  2019cites this paper
• Pulmonary Disease in Cystic Fibrosis

  2019cites this paper
• The role of CFTR in normal human lung microvascular endothelial cells

  2019cites this paper
• Reduction of neutrophilic inflammation in idiopathic pulmonary fibrosis via metabolism of n-alpha-pgp by leukotriene A4 hydrolase

  2018cites this paper
• Complement effectors, C5a and C3a, in cystic fibrosis lung fluid correlate with disease severity

  2017cites this paper
• Proteomic profiling identifies novel circulating markers associated with bronchiectasis in cystic fibrosis

  2017cites this paper
• Interactions between Neutrophils and Pseudomonas aeruginosa in Cystic Fibrosis

  2017cites this paper
• Proteases Revisited: Roles and Therapeutic Implications in Fibrosis

  2017cites this paper
• Inflammatory mechanisms in cystic fibrosis lung disease

  2017cites this paper
• Soluble CD59 is a Novel Biomarker for the Prediction of Obstructive Chronic Lung Allograft Dysfunction After Lung Transplantation

  2016cites this paper
• Complement Effectors of Inflammation in Cystic Fibrosis Lung Fluid Correlate with Clinical Measures of Disease

  2015cites this paper
• Complement mediators: key regulators of airway tissue remodeling in asthma

  2015cites this paper
• Leukocytes: The Double-Edged Sword in Fibrosis

  2015cites this paper
• Mechanisms of immune dysfunction and bacterial persistence in non-cystic fibrosis bronchiectasis.

  2013cites this paper
• Antiproteases as Therapeutics to Target Inflammation in Cystic Fibrosis

  2010cites this paper
• Microbial Hijacking of Complement–Toll-Like Receptor Crosstalk

  2010cites this paper
• Antiproteases as therapeutics to target inflammation in cystic fibrosis.

  2010cites this paper
• Chapter 14 – The Neutrophil and Its Special Role in Chronic Obstructive Pulmonary Disease

  2009cites this paper
• Neutrophils in cystic fibrosis

  2008cites this paper
• Characterisation of the range of neutrophil stimulating mediators in cystic fibrosis sputum

  2008cites this paper
• Multiple routes of complement activation by Mycobacterium bovis BCG.

  2008cites this paper
• Host Defense Systems of the Lung

  2008cites this paper
• The Macrophage in Cystic Fibrosis

  2007cites this paper
• Function, structure and therapeutic potential of complement C5a receptors

  2007cites this paper
• Inflammatory lung secretions inhibit dendritic cell maturation and function via neutrophil elastase.

  2006cites this paper
• Endothelial activation and increased heparan sulfate expression in cystic fibrosis.

  2005cites this paper
• Molecular Characterization of the Gerbil C5a Receptor and Identification of a Transmembrane Domain V Amino Acid That Is Crucial for Small Molecule Antagonist Interaction*

  2005cites this paper
• Proteinases in COPD

  2004cites this paper
• Free secretory component from cystic fibrosis sputa displays the cystic fibrosis glycosylation phenotype.

  2004cites this paper
• Inhalative Antibiotikatherapie bei Cystischer Fibrose Eine retrospektive Beurteilung aus mikrobiologischer Sicht

  2004cites this paper
• Free secretory component from cystic fibrosis sputa displays the CF glycosylation phenotype.

  2003cites this paper
• Characterization of a novel chemotactic factor for neutrophils in the bronchial secretions of patients with cystic fibrosis.

  2002cites this paper
• The role of inflammation in the pathophysiology of CF lung disease

  2002cites this paper
• Immunization with a Pseudomonas aeruginosa elastase peptide reduces severity of experimental lung infections due to P. aeruginosa Or Burkholderia cepacia.

  2000cites this paper
• Factors influencing airway inflammation in chronic obstructive pulmonary disease

  2000cites this paper
• Generation of complement C3 and expression of cell membrane complement inhibitory proteins by human bronchial epithelium cell line

  2000cites this paper
• Factors influencing airway inflammation in chronic obstructive pulmonary disease

  2000cites this paper
• Respiratory Bacterial Infections in Patients with Cystic Fibrosis: Pathogenicity and Implications for Serine Proteinase Inhibitor Therapy

  1999cites this paper
• The protease-antiprotease battle in the cystic fibrosis lung

  1999cites this paper
• Nitrite Reductase from Pseudomonas aeruginosa Released by Antimicrobial Agents and Complement Induces Interleukin-8 Production in Bronchial Epithelial Cells

  1999cites this paper
• The effect of interleukin-8 and granulocyte macrophage colony stimulating factor on the response of neutrophils to formyl methionyl leucyl phenylalanine.

  1998cites this paper
• Cytokines modulate expression of cell-membrane complement inhibitory proteins in human lung cancer cell lines.

  1998cites this paper
• Chemotactic factors in bronchial secretions of cystic fibrosis patients.

  1998cites this paper
• The chemotactic activity of sputum from patients with bronchiectasis.

  1998cites this paper
• Identification of neutrophil chemotactie factors in bronchoalveolar lavage fluid of asthmatic patients

  1997cites this paper
• Interleukin-8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis or idiopathic pulmonary fibrosis.

  1997cites this paper
• Inflammatory bronchopulmonary response of preterm infants with microbial colonisation of the airways at birth.

  1996cites this paper
• Anti‐inflammatory therapy in cystic fibrosis

  1996cites this paper
• Protection of human nasal respiratory epithelium from complement-mediated lysis by cell-membrane regulators of complement activation.

  1996cites this paper
• Role of corticosteroids in cystic fibrosis lung disease.

  1996cites this paper
• Effect of nebulised recombinant DNase on neutrophil elastase load in cystic fibrosis.

  1996cites this paper
• Expression and distribution of cell-membrane complement regulatory glycoproteins along the human respiratory tract.

  1995cites this paper
• Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung.

  1995cites this paper
• The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis

  1995cites this paper
• Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation.

  1994cites this paper
• Atopic children with cystic fibrosis have increased urinary leukotriene E4 concentrations and more severe pulmonary disease.

  1994cites this paper
• Neutrophil collagenase in sputum from patients with cystic fibrosis.

  1994cites this paper
• Interleukin-1cx, soluble interleukin-2 receptor, andIgGconcentrations incystic fibrosis treated withprednisolone

  1994cites this paper
• Pathophysiology of Pulmonary Disease in Cystic Fibrosis

  1994cites this paper
• The immunopathology of chemotactic cytokines: the role of interleukin-8 and monocyte chemoattractant protein-1.

  1994cites this paper
• Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases

  1994cites this paper
• Normal serum increases adhesion of neutrophils to tracheal epithelial cells by a CD11b/CD18-dependent mechanism.

  1994cites this paper
• Levels of Complement Anaphylatoxin C5a in Pulmonary Effluent Fluid of Infants at Risk for Chronic Lung Disease and Effects of Dexamethasone Treatment

  1993cites this paper
• Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases.

  1993cites this paper
• Eicosapentaenoic acid in cystic fibrosis: evidence of a pathogenetic role for leukotriene B4.

  1993cites this paper
• [Passive immunotherapy for treatment of endobronchitis in cystic fibrosis].

  1993cites this paper
• Carotenoid levels in normal children and in children with cystic fibrosis.

  1993cites this paper
• Leukotriene B4 markedly elevated in the epithelial lining fluid of patients with cystic fibrosis.

  1993cites this paper
• Corticosteroid treatment in cystic fibrosis.

  1993cites this paper
• Genetics of asthma.

  1993cites this paper
• Acquired Resistance to P. aeruginosa

  1993cites this paper
• alpha 1-Proteinase inhibitor, elastase activity, and lung disease severity in cystic fibrosis.

  1993cites this paper
• Neutrophil chemotactic factors in the respiratory tract of patients with chronic airway diseases or idiopathic pulmonary fibrosis.

  1992cites this paper
• Decreased polymorphonuclear leucocyte chemotactic response to leukotriene B4 in cystic fibrosis

  1992cites this paper
• Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line.

  1992cites this paper
• The pathogenesis of Pseudomonas aeruginosa lung infections in cystic fibrosis

  1992cites this paper
• Inflammation in the lung in cystic fibrosis. A vicious cycle that does more harm than good?

  1991cites this paper
• Complement deposition by antibodies to Pseudomonas aeruginosa mucoid exopolysaccharide (MEP) and by non-MEP specific opsonins.

  1991cites this paper
• Inflammation in the lung in cystic fibrosis

  1991cites this paper
• Complement activation by cigarette smoke.

  1991cites this paper
• On the proteolytic activity of contact lenses and bacteria

  1990cites this paper
• Generation and metabolism of leukotrienes in granulocytes of patients with cystic fibrosis.

  1990cites this paper
• Chemotactic factor inactivator interaction with Gc-globulin (vitamin D-binding protein). A mechanism of modulating the chemotactic activity of C5a.

  1990cites this paper
• Increased phagocytic cell chemiluminescence in patients with cystic fibrosis.

  1989cites this paper
• Pathogenesis of the pseudomonas lung lesion in cystic fibrosis.

  1989cites this paper
• Pathophysiologic Mechanisms in the Lung Lesion of Pseudomonas aeruginosa

  1989cites this paper
• Neutrophil chemotactic factors in bacterial pneumonia.

  1989cites this paper
• Pseudomonas aeruginosa and the airways disease of cystic fibrosis.

  1988cites this paper
• Mechanisms of neutrophil recruitment to the lung by grain dust exposure.

  1988cites this paper
• Pulmonary host defense: defects that lead to chronic inflammation of the airway.

  1988cites this paper
• Detection of native human complement components C3 and C5 and their primary activation peptides C3a and C5a (anaphylatoxic peptides) by ELISAs with monoclonal antibodies.

  1988cites this paper